Skip to Content

Biotech Drug Factory

A photo essay: Inside Genetech’s South San Francisco manufacturing plant
March 1, 2006

Last year, Genentech, a global leader in the manufacture of genetically engineered drugs, had sales of about $5.5 billion. A “biotech drug” is one that uses a protein to treat a particular disorder: to make its protein-based drugs, which include cancer treatments and a human growth hormone, Genentech must grow vast quantities of therapeutic proteins in host cells and then harvest them.

The company can ferment approximately 280,000 liters of cell culture at any one time at its various manufacturing plants.

This photo essay illustrates the production process at Genentech’s South San Francisco plant, from the testing and fine-tuning of manufacturing techniques, to the fermentation of cells, to the purification of drugs that will be shipped around the world.

[Click here for the images.]

Keep Reading

Most Popular

Large language models can do jaw-dropping things. But nobody knows exactly why.

And that's a problem. Figuring it out is one of the biggest scientific puzzles of our time and a crucial step towards controlling more powerful future models.

OpenAI teases an amazing new generative video model called Sora

The firm is sharing Sora with a small group of safety testers but the rest of us will have to wait to learn more.

Google’s Gemini is now in everything. Here’s how you can try it out.

Gmail, Docs, and more will now come with Gemini baked in. But Europeans will have to wait before they can download the app.

This baby with a head camera helped teach an AI how kids learn language

A neural network trained on the experiences of a single young child managed to learn one of the core components of language: how to match words to the objects they represent.

Stay connected

Illustration by Rose Wong

Get the latest updates from
MIT Technology Review

Discover special offers, top stories, upcoming events, and more.

Thank you for submitting your email!

Explore more newsletters

It looks like something went wrong.

We’re having trouble saving your preferences. Try refreshing this page and updating them one more time. If you continue to get this message, reach out to us at customer-service@technologyreview.com with a list of newsletters you’d like to receive.